Lifecore Biomedical Inc (LFCR)
5.875
+0.20
(+3.43%)
USD |
NASDAQ |
Nov 01, 16:00
5.88
0.00 (0.00%)
After-Hours: 20:00
Lifecore Biomedical Net Income (Quarterly): -16.23M for Aug. 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | -16.23M |
| May 31, 2024 | -7.083M |
| February 29, 2024 | 15.63M |
| November 30, 2023 | 14.22M |
| August 31, 2023 | -10.75M |
| May 31, 2023 | -39.28M |
| February 28, 2023 | -36.51M |
| November 30, 2022 | -12.81M |
| August 31, 2022 | -10.97M |
| May 31, 2022 | -55.60M |
| February 28, 2022 | -13.09M |
| November 30, 2021 | -38.44M |
| August 31, 2021 | -9.477M |
| May 31, 2021 | -2.495M |
| February 28, 2021 | -5.498M |
| November 30, 2020 | -13.30M |
| August 31, 2020 | -11.00M |
| May 31, 2020 | -15.15M |
| February 29, 2020 | -11.52M |
| November 30, 2019 | -6.74M |
| August 31, 2019 | -4.784M |
| May 31, 2019 | -0.261M |
| February 28, 2019 | 1.067M |
| November 30, 2018 | -0.584M |
| August 31, 2018 | 0.19M |
| Date | Value |
|---|---|
| May 31, 2018 | 6.108M |
| February 28, 2018 | 16.09M |
| November 30, 2017 | 0.487M |
| August 31, 2017 | 2.146M |
| May 31, 2017 | 2.452M |
| February 28, 2017 | 3.50M |
| November 30, 2016 | 1.326M |
| August 31, 2016 | 3.312M |
| May 31, 2016 | 4.729M |
| February 29, 2016 | -21.19M |
| November 30, 2015 | 1.868M |
| August 31, 2015 | 2.952M |
| May 31, 2015 | 4.196M |
| February 28, 2015 | 3.772M |
| November 30, 2014 | 3.223M |
| August 31, 2014 | 2.353M |
| May 31, 2014 | 4.542M |
| February 28, 2014 | 6.40M |
| November 30, 2013 | 3.451M |
| August 31, 2013 | 4.752M |
| May 31, 2013 | 4.519M |
| February 28, 2013 | 4.789M |
| November 30, 2012 | 8.913M |
| August 31, 2012 | 4.366M |
| May 31, 2012 | 2.779M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-55.60M
Minimum
May 2022
15.63M
Maximum
Feb 2024
-14.30M
Average
-11.26M
Median
Net Income (Quarterly) Benchmarks
| AngioDynamics Inc | -12.80M |
| Precision Optics Corp Inc | -1.411M |
| Sage Therapeutics Inc | -93.55M |
| Outset Medical Inc | -34.45M |
| NovaBay Pharmaceuticals Inc | -1.585M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 24.70M |
| Total Expenses (Quarterly) | 35.81M |
| EPS Diluted (Quarterly) | -0.53 |
| Enterprise Value | 338.76M |
| Gross Profit Margin (Quarterly) | 21.81% |
| Profit Margin (Quarterly) | -65.70% |
| Earnings Yield | 0.85% |
| Normalized Earnings Yield | -15.15 |